The Genetics and Ocular Findings of Alagille Syndrome

REFERENCES

• Watson G H, Miller V. Arteriohepatic dysplasia. Familial pulmonary artery stenosis with neonatal liver disease. Arch Dis Child 1973; 48: 459–66
   PubMed Web of Science ®Google Scholar
• Alagille D, Odievre M, Gautier M, et al. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. J Pediatr 1975; 86: 63–71
   PubMed Web of Science ®Google Scholar
• Li L, Krantz I D, Deng Y, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997; 16: 243–51
   PubMed Web of Science ®Google Scholar
• Riely C A, Cotlier E, Jensen P S. Arteriohepatic dysplasia: A benign syndrome of intrahepatic cholestasis with multiple organ involvement. Ann Intern Med 1979; 91: 520–7
   PubMed Web of Science ®Google Scholar
• Krantz I D, Piccoli D A, Spinner N B. Alagille syndrome. J Med Genet 1997; 34: 152–7
   PubMedGoogle Scholar
• Oda T, Elkahloun A G, Pike B L. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997; 16: 235–42
   PubMed Web of Science ®Google Scholar
• Spinner N B, Colliton R P, Crosnier C, et al. Jagged1 mutations in Alagille syndrome. Hum Mutat 2001; 17(1)18–33
   Google Scholar
• Boyer J, Crosnier C, Driancourt C, et al. Expression of mutant JAGGED1 alleles in patients with Alagille syndrome. Hum Genet 2005; 116: 445–53
   Google Scholar
• Gridley T. Notch signaling and inherited disease syndromes. Hum Mol Genet 2003; 12: R9–13, SpecNo1
   PubMedGoogle Scholar
• Li L, Milner L A, Deng Y, et al. The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity 1998; 8: 43–55
   PubMed Web of Science ®Google Scholar
• Bao Z, Cepko C L. The expression and function of Notch pathway genes in the developing rat eye. J Neurosci 1997; 17(4)1425–34
   Google Scholar
• Bray S J. Notch signaling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006; 7: 678–89
   PubMed Web of Science ®Google Scholar
• Xue Y, Gao X, Lindsell C E. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Molec Genet 1999; 8: 723–30
   PubMed Web of Science ®Google Scholar
• McCright B, Lozier J, Gridley T. A mouse model of Alagille syndrome:Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002; 129: 1075–82
   PubMed Web of Science ®Google Scholar
• Heitzler P, Simpson P. The choice of cell fate in the epidermis of drosophila. Cell 1991; 64: 1083–92
   PubMed Web of Science ®Google Scholar
• McDaniell R, Warthen D M, Sanchez-Lara P A, et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the Notch signaling pathway. Am J Hum Genet 2006; 79: 169–73
   PubMed Web of Science ®Google Scholar
• Kamath B M, Krantz I D, Spinner N B, et al. Monozygotic twins with a severe form of Alagille syndrome and phenotypic discordance. Am J Med Genet 2002; 112: 194–7
   PubMed Web of Science ®Google Scholar
• Wells K K, Pulido J S, Judisch G F, et al. Ophthalmic features of Alagille syndrome (arteriohepatic dysplasia). J Pediatr Ophthalmol Strabismus 1993; 30: 130–5
   Google Scholar
• Hingorani M, Nischal K K, Davies A, et al. Ocular abnormalities in Alagille syndrome. Ophthalmology 1999; 106: 330–7
   PubMed Web of Science ®Google Scholar
• Romanchuk K G, Judisch G F, La Brecque D R. Ocular findings in arteriohepatic dysplasia (Alagille's syndrome). Can J Ophthalmol 1981; 16: 94–9
   Google Scholar
• Puklin J E, Riely C A, Simon R M, et al. Anterior segment and retinal pigmentary abnormalities in arteriohepatic dysplasia. Ophthalmology 1981; 88: 337–47
   Google Scholar
• Brodsky M C, Cunniff C. Ocular anomalies in the Alagille syndrome (arteriohepatic dysplasia). Ophthalmology 1993; 100: 1767–74
   Google Scholar
• Waring G O, Rodrigues M M, Laibson P R. Anterior chamber cleavage syndrome. A stepladder classification. Surv Ophthalmol 1975; 20(1)3–27
   Google Scholar
• Traboulsi E I, Lustbader J M, Lemp M A. Keratoconus in Alagille's syndrome. Am J Ophthalmol 1989; 108: 332–3
   Google Scholar
• Nischal K K, Hingorani M, Bentley C R, et al. Ocular ultrasound in Alagille syndrome: a new sign. Ophthalmology 1997; 104: 79–85
   Google Scholar
• Narula P, Gifford J, Steggall M A, et al. Visual loss and idiopathic intracranial hypertension in children with Alagille syndrome. J Pediatr Gastroenterol Nutr 2006; 43: 348–52
   Google Scholar
• Fea A, Grosso A, Rabbione M, et al. Alagille syndrome and optic pit. Graefes Arch Clin Exp Ophthalmol 2007; 245(2)315–7
   Google Scholar
• Kamath B M, Spinner N B, Emerick K M, et al. Vascular anomalies in Alagille syndrome: A significant cause of morbidity and mortality. Circulation 2004; 109: 1354–8
   PubMed Web of Science ®Google Scholar
• Johnson B L. Ocular pathologic features of arteriohepatic dysplasia (Alagille's syndrome). Am J Ophthalmol 1990; 110: 504–12
   Google Scholar
• Tanino T, Ishihara A, Naganuma K, et al. Electrophysiological findings in a family with congenital arteriohepatic dysplasia (Alagille syndrome). Doc Ophthalmol 1986; 63: 83–9
   Google Scholar